| | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 游资净占比 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2026-01-15 | 38.08 | -3.57% | 2193.13万 | 5.01% | 2327.35万 | 5.32% | -4520.48万 | -10.34% | | 2026-01-14 | 39.49 | -0.23% | - -357.24万 | -1.14% | -153.44万 | -0.49% | 510.69万 | 1.63% | | 2026-01-13 | | 39.58 -0.38% | 572.79万 | 2.36% | -475.16万 | -1.96% | -97.63万 | -0.40% | | 2026-01-12 | 39.73 | 1.43% | -293.22万 | -1.24% | -6.78万 | -0.03% | 300.00万 | 1.27% | | 2026-01-09 | 39.17 | 1.03% | -268 ...

该股主要指标及行业内排名如下： 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-203.6万元，毛利率 48.32%。稳健医疗（300888）主营业务：棉类制品的研发、生产、销售,覆盖医疗卫生、个人护理、家 庭护理、母婴护理、家纺服饰等。 该股最近90天内共有22家机构给出评级，买入评级18家，增持评级4家；过去90天内机构目标均价为 54.88。 证券之星消息，截至2026年1月14日收盘，稳健医疗(300888)报收于39.49元，下跌0.23%，换手率 1.36%，成交量7.91万手，成交额3.14亿元。 1月14日的资金流向数据方面，主力资金净流出357.24万元，占总成交额1.14%，游资资金净流出153.44 万元，占总成交额0 ...

证券之星消息，截至2026年1月12日收盘，稳健医疗(300888)报收于39.73元，上涨1.43%，换手率 1.03%，成交量5.98万手，成交额2.36亿元。 1月12日的资金流向数据方面，主力资金净流出293.22万元，占总成交额1.24%，游资资金净流出6.78万 元，占总成交额0.03%，散户资金净流入300.0万元，占总成交额1.27%。 近5日资金流向一览见下表： 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-203.6万元，毛利率 48.32%。稳健医疗（300888）主营业务：棉类制品的研发、生产、销售,覆盖医疗卫生、个人护理、家 庭护理、母婴护理、家纺服饰等。 该股最近90天内共有22家机构给出评级，买入评级18家， ...

证券之星消息，截至2026年1月9日收盘，稳健医疗(300888)报收于39.17元，上涨1.03%，换手率 0.73%，成交量4.26万手，成交额1.66亿元。 1月9日的资金流向数据方面，主力资金净流出268.42万元，占总成交额1.62%，游资资金净流出660.0万 元，占总成交额3.98%，散户资金净流入928.41万元，占总成交额5.59%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元，同比上升43.93%；其中2025年第三季度，公司单季度主营 收入26.01亿元，同比上升27.71%；单季度归母净利润2.4亿元，同比上升42.11%；单季度扣非净利润 2.18亿元，同比上升50.77%；负债率33.87%，投资收益3323.27万元，财务费用-203.6万元，毛利率 48.32%。稳健医疗（30088 ...

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of the company Steady Medical (300888), including stock price movements and funding flows [1][2]. - As of January 7, 2026, Steady Medical's stock closed at 38.6 yuan, down 1.08%, with a trading volume of 47,000 hands and a transaction amount of 182 million yuan [1]. - In terms of funding flow on January 7, 2026, the main capital saw a net inflow of 6.1 million yuan, accounting for 3.35% of the total transaction amount, while retail investors experienced a net outflow of 123,700 yuan, representing 0.07% of the total [1]. Group 2 - For the first three quarters of 2025, Steady Medical reported a main revenue of 7.897 billion yuan, a year-on-year increase of 30.1%, and a net profit attributable to shareholders of 732 million yuan, up 32.36% [2]. - The third quarter of 2025 alone saw a main revenue of 2.601 billion yuan, reflecting a year-on-year growth of 27.71%, with a net profit of 240 million yuan, increasing by 42.11% [2]. - The company has a debt ratio of 33.87%, with investment income of 33.23 million yuan and a gross profit margin of 48.32% [2].

Core Viewpoint - The stock of Steady Medical (300888) has shown a positive performance with a closing price of 39.34 yuan, reflecting a 3.96% increase as of January 5, 2026, with significant trading activity noted [1]. Financial Performance - For the first three quarters of 2025, Steady Medical reported a main revenue of 7.897 billion yuan, representing a year-on-year increase of 30.1% [2]. - The net profit attributable to shareholders reached 732 million yuan, up 32.36% year-on-year, while the net profit excluding non-recurring items was 679 million yuan, marking a 43.93% increase [2]. - In Q3 2025 alone, the company achieved a quarterly main revenue of 2.601 billion yuan, a 27.71% increase year-on-year, with a quarterly net profit of 240 million yuan, reflecting a 42.11% rise [2]. - The company's debt ratio stands at 33.87%, with investment income of 33.23 million yuan and financial expenses of -2.036 million yuan, alongside a gross profit margin of 48.32% [2]. Market Sentiment - Over the past 90 days, 21 institutions have provided ratings for Steady Medical, with 17 recommending a buy and 4 suggesting an increase in holdings [2]. - The average target price set by institutions for the stock over the last 90 days is 5.488 billion yuan [2].

Group 1 - The core viewpoint of the news is that Steady Medical (300888) has shown significant growth in its financial performance for the first three quarters of 2025, with a notable increase in revenue and net profit compared to the previous year [2] - For the first three quarters of 2025, the company's main revenue reached 7.897 billion yuan, representing a year-on-year increase of 30.1%, while the net profit attributable to shareholders was 732 million yuan, up 32.36% [2] - In Q3 2025 alone, the company reported a single-quarter main revenue of 2.601 billion yuan, which is a 27.71% increase year-on-year, and a net profit of 240 million yuan, reflecting a 42.11% increase [2] Group 2 - The company's debt ratio stands at 33.87%, with investment income of 33.23 million yuan and financial expenses of -2.036 million yuan, indicating a strong financial position [2] - The gross profit margin for Steady Medical is reported at 48.32%, showcasing the company's efficiency in managing costs relative to its revenue [2] - Over the past 90 days, 21 institutions have provided ratings for the stock, with 17 recommending a buy and 4 recommending an increase in holdings, while the average target price set by institutions is 5.488 billion yuan [2]

证券之星消息，截至2025年12月23日收盘，稳健医疗(300888)报收于38.23元，下跌0.78%，换手率 0.35%，成交量2.03万手，成交额7761.43万元。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状态时主动性买单形成的成交额是推 动股价上涨的力量，这部分成交额被定义为资金流入，股价处于下跌状态时主动性卖单产生的的成交额 是推动股价下跌的力量，这部分成交额被定义为资金流出。当天两者的差额即是当天两种力量相抵之后 剩下的推动股价上升的净力。通过逐笔交易单成交金额计算主力资金流向、游资资金流向和散户资金流 向。 12月23日的资金流向数据方面，主力资金净流入487.4万元，占总成交额6.28%，游资资金净流出824.48 万元，占总成交额10.62%，散户资金净流入337.09万元，占总成交额4.34%。 注：主力资金为特大单成交，游资为大单成交，散户为中小单成交 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 稳健医疗2025年三季报显示，前三季度公司主营收入78.97亿元，同比上升30.1%；归母净利润7.32亿 元，同比上升32.36%；扣非净利润6.79亿元， ...

Group 1 - The core viewpoint of the news is that Steady Medical (300888) has shown significant growth in its financial performance for the first three quarters of 2025, with a notable increase in revenue and net profit compared to the previous year [2] - As of December 15, 2025, Steady Medical's stock closed at 37.43 yuan, down 1.03%, with a turnover rate of 0.43% and a trading volume of 24,800 hands, resulting in a transaction amount of 93.56 million yuan [1] - The company's main business includes the research, production, and sales of cotton products, covering medical health, personal care, family care, maternal and infant care, and home textiles [2] Group 2 - For the first three quarters of 2025, Steady Medical reported a main operating income of 7.897 billion yuan, a year-on-year increase of 30.1%, and a net profit attributable to shareholders of 732 million yuan, up 32.36% [2] - In the third quarter of 2025 alone, the company achieved a main operating income of 2.601 billion yuan, representing a year-on-year increase of 27.71%, and a net profit of 240 million yuan, up 42.11% [2] - The company has a debt ratio of 33.87%, with investment income of 33.23 million yuan and a gross profit margin of 48.32% [2]

Core Viewpoint - The stock of Steady Medical (300888) shows a slight increase in price and mixed capital flow data, indicating varying investor sentiment and potential opportunities for analysis [1][2]. Group 1: Stock Performance - As of December 12, 2025, Steady Medical's stock closed at 37.82 yuan, with a minor increase of 0.03% and a turnover rate of 0.51% [1]. - The trading volume on December 12 was 29,600 hands, with a total transaction value of 112 million yuan [1]. Group 2: Capital Flow Analysis - On December 12, the net inflow of main funds was 3.93 million yuan, accounting for 3.52% of the total transaction value, while retail investors saw a net inflow of 586,800 yuan, representing 0.52% [1][2]. - Over the past five days, the main funds experienced fluctuations, with a notable net outflow of 7.73 million yuan on December 11, and a significant net outflow of 11.59 million yuan on December 8 [2]. Group 3: Financial Metrics and Industry Ranking - Steady Medical's total market capitalization is 22.024 billion yuan, ranking third in the beauty and personal care industry, which has an average market cap of 9.825 billion yuan [3]. - The company reported a net profit of 732 million yuan for the first three quarters of 2025, reflecting a year-on-year increase of 32.36% [3]. - The gross profit margin for Steady Medical stands at 48.32%, which is higher than the industry average of 42.35% [3]. Group 4: Institutional Ratings - In the last 90 days, 20 institutions have rated Steady Medical, with 17 buy ratings and 3 hold ratings, indicating a generally positive outlook [4]. - The average target price set by institutions over the past 90 days is 54.88 yuan [4].